HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
$3.00 per share
$3.00 per share
Est. EPS $6.75 · Revenue $19.35B · 14 analysts
Est. EPS $6.80
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $75.6B | +7.1% | +5.9% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $6.8B | +17.8% | +4.9% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +41.5% | +2.2% | +1.2% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | +15.8% | +5.9% | +1.2% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | +9.0% | +10.0% | -0.9% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $7.7B | +36.4% | +23.4% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +10.2% | +27.4% | +16.5% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | -832.9% | +54.0% | +6.2% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 0.83x | -23.3% | -6.3% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $60.7B | +2.0% | -1.5% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | 28.38 vs 27.68 | +2.5% | 7.62 vs 6.75 | +12.9% |
| Revenue Surprise | $75.6B vs $75.7B | -0.2% | $20.2B vs $19.4B | +4.5% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | McAlevey Michael R | officer: EVP & Chief Legal & Admin Off. | Common Stock | D | 7,769 | $429.00 |
| May 7, 2026 | Marks Mike A | officer: EVP and CFO | Common Stock | A | 3,336 | — |
| May 7, 2026 | Marks Mike A | officer: EVP and CFO | Common Stock | D | 3,336 | — |
| Apr 28, 2026 | Frist William R | director, 10 percent owner: | Common Stock, par value $0.01 per share | A | 809 | — |
| Apr 28, 2026 | FRIST THOMAS F III | director, 10 percent owner: | Common Stock, par value $0.01 per share | A | 1,041 | — |
Ladies and gentlemen, welcome to the HCA Healthcare Second Quarter 2026 Earnings Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank George Morgan. Please go ahead, sir.
Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Samuel N. Hazen, and CFO, Mike Marks. Samuel and Mike will provide some prepared remarks and then we will take questions. Before I turn the call over to Samuel, let me remind you that should today's call contain any forward-looking statements, they are based on management's current expectations. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings. Over this morning's call, we may reference measures such as adjusted EBITDA, a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA, and reconciling net income attributable to HCA Healthcare Inc. is included in today's release. This morning's call is being recorded, and a replay of the call will be available later today. With that, I will now turn the call over to Samuel.
Good morning. We believe that access to health care and affordability for Americans begins and ends with health insurance coverage. Most people need support to secure it, whether that is through an employer, the federal government, or some other means. Throughout 2025, our teams advocated for extending in some form the enhanced premium tax credits for those individuals who needed it. Unfortunately, the enhanced premium tax credits expired at the end of the year, and the effects, as expected, were that many people became uninsured and still needed emergency care from hospitals. As we look at the first half of the year, our expectations proved accurate, although the impact was greater than our estimates. Our colleagues, however, have continued to deliver high-quality, compassionate care to an increased number of patients during the first half of the year while managing well through the various headwinds we faced. On behalf of our board and our senior team, I want to thank our colleagues for their great work. When I look at the company's midyear results, I focus on three factors. But before I get to those, I do want to indicate that the company had solid diluted earnings per share growth of 11% in the quarter, and 11% year to date. First, we experienced an unfavorable payer mix shift which created most of the financial pressure for the company. Overall, adjusted admissions for patients who were formerly covered by the health insurance exchanges declined by 15%. We expected that some of these patients would shift to other forms of coverage, but this did not happen. Instead, these patients migrated almost …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Samuel N. Hazen | Chief Executive Officer & Director | USD 7,533,573 | Male | 1960 | Active |
Jon Mack Foster | Executive Vice President & Chief Operating Officer | USD 3,755,736 | Male | 1962 | Active |
Michael A. Marks | Chief Financial Officer & Executive Vice President | USD 3,489,035 | Male | 1970 | Active |
Michael R. McAlevey | Executive Vice President and Chief Legal & Administrative Officer | USD 3,166,950 | Male | 1964 | Active |
Michael S. Cuffe | Executive Vice President & Chief Clinical Officer | USD 3,160,812 | — | 1966 | Active |
Thomas F. Frist Jr. | Founder & Chairman Emeritus | USD 17,973 | — | 1939 | Active |
Chad J. Wasserman | Senior Vice President & Chief Information Officer | — | Male | — | Active |
Christopher F. Wyatt | Senior Vice President, Principal Accounting Officer & Controller | — | Male | 1978 | Active |
Wendy Warren | Senior Vice President and Chief Ethics & Compliance Officer | — | Female | — | Active |
Frank George Morgan | Vice President of Investor Relations | — | Male | — | Active |
Assenagon Asset Management S.A. lessened its holdings in HCA Healthcare, Inc. (NYSE: HCA) by 81.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,001 shares of the company's stock after selling 63,779 shares during the period. Assenagon
Deane Retirement Strategies Inc. acquired a new stake in shares of HCA Healthcare, Inc. (NYSE: HCA) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 12,298 shares of the company's stock, valued at approximately $4,796,000. HCA Healthcare comprises 2.0%
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare's East Florida Division, has been appointed president of HCA Healthcare's new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Fortinet, Inc. (NASDAQ:FTNT) is good and he likes it. “They're doing a good job,” he added.
